Norden Group’s Guardant Health GH Stock Holding History

Norden Group’s Portfolio GH Stock Details GH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$376K	Sell	2,505 -14	-0.6%	-$1.52K	0.03%	461
2026 Q1	$233K	Buy	2,519 +447	+22%	+$44.9K	0.02%	538
2025 Q4	$212K	Buy	+2,072	New	+$185K	0.02%	580

Other funds holding GH

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Norden Group's GH Position: Q2 2026 in Review

Norden Group reduced its Guardant Health (GH) stake by 0.56% in Q2 2026, selling an estimated $1.52K and leaving 2,505 shares worth $376K. The position accounts for 0.03% of the portfolio, ranked #461.

Norden Group first reported a position in GH in Q4 2025 and has held it in 3 quarters since. 597 funds tracked by Wall St. Rank hold GH as of Q2 2026.

Norden Group held 2,505 shares of Guardant Health worth $376K as of Q2 2026.
Norden Group sold 14 Guardant Health shares in Q2 2026, an estimated $1.52K.
Guardant Health made up 0.03% of Norden Group's portfolio in Q2 2026, its #461 holding.
Norden Group first reported a position in Guardant Health in Q4 2025 and has held it in 3 quarters since.
597 funds tracked by Wall St. Rank held Guardant Health as of Q2 2026.

Based on Norden Group's 13F filing for Q2 2026, filed 29 Jul 2026.